Published in Front Microbiol on May 15, 2015
Hepatitis C in Cameroon: What is the progress from 2001 to 2016? J Transl Int Med (2016) 0.75
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res (1982) 11.72
Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect (2011) 6.48
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol (1994) 4.21
The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology (2006) 2.35
Antiviral strategies in hepatitis C virus infection. J Hepatol (2012) 2.25
Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol (2006) 1.99
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut (2014) 1.70
Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol (2007) 1.69
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology (2011) 1.52
Polyphenol content and antioxidant activity of fourteen wild edible fruits from Burkina Faso. Molecules (2008) 1.46
Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication. J Virol (2009) 1.43
(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology (2012) 1.34
Hepatitis C virus infection in cameroon: A cohort-effect. J Med Virol (2005) 1.18
A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology (2012) 1.06
Hepatitis C virus and natural compounds: a new antiviral approach? Viruses (2012) 1.03
Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon. J Med Virol (2002) 1.02
Phytochemistry and biology of Loranthus parasiticus Merr, a commonly used herbal medicine. Am J Chin Med (2014) 0.97
Anti-hepatitis C virus activity of 3-hydroxy caruilignan C from Swietenia macrophylla stems. J Viral Hepat (2011) 0.94
(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus. Arch Virol (2012) 0.93
In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infection. Phytother Res (2010) 0.91
Ledipasvir/Sofosbuvir: a review of its use in chronic hepatitis C. Drugs (2015) 0.90
Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1. J Gen Virol (2013) 0.90
Anti-hepatitis C virus activity of crude extract and fractions of Entada africana in genotype 1b replicon systems. Am J Chin Med (2014) 0.86
Bioactive diterpenes from the fruits of Detarium microcarpum. J Nat Prod (2006) 0.83
Bioassay-guided isolation of neuroprotective compounds from Loranthus parasiticus against H₂O₂-induced oxidative damage in NG108-15 cells. J Ethnopharmacol (2011) 0.82
Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus. Virol J (2013) 0.80
[Experimental research on inhibitory effect of alcohol extracts from Loranthus yadoriki Sieb. on coxsackie B3 virus]. Zhongguo Zhong Yao Za Zhi (2000) 0.80
Inhibition of microsomal lipid peroxidation and protein oxidation by extracts from plants used in Bamun folk medicine (Cameroon) against hepatitis. Afr J Tradit Complement Altern Med (2008) 0.80
Relapses in the treatment of genotype 2 viral hepatitis C, a cause of concern in the blacks. Indian J Gastroenterol (2014) 0.79
Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection. Phytother Res (2009) 0.78
Carbohydrates from Detarium microcarpum bark extract. Carbohydr Res (2002) 0.76